Page 18 - Managed Care News Today

In 2023, there were 18 oncology and 7 population health Institute for Value-Based Medicine® events cohosted with organizations such as Optum, OneOncology, Vanderbilt Ingram Cancer Center, Duke Health, Cleveland Clinic, and Memorial Sloan Kettering Cancer Center.

The top 5 most-read articles on sleep published on AJMC.com this year include content focusing on narcolepsy management, approval of medication to treat insomnia, and the association of metabolic syndrome with sleep duration.

B & T Capital Management DBA Alpha Capital Management grew its position in shares of Centene Co. (NYSE:CNC – Free Report) by 8.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 31,735 shares of the company’s stock after purchasing an additional 2,537 shares […]

Mount Yale Investment Advisors LLC reduced its holdings in Centene Co. (NYSE:CNC – Free Report) by 17.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,796 shares of the company’s stock after selling 1,232 shares during the period. Mount Yale Investment Advisors LLC’s […]

California's safety-net health program, Medi-Cal, is on the cusp of major changes that could rectify long-standing problems and improve health care for the state's low-income population.

A group of volunteers took to Grand Rapids with one goal in mind: making sure foster children have comfort on their first night with their new foster families.

The state's Medicaid managed care contract is worth an estimated $15.5 billion over five years.

Centene (NYSE:CNC – Free Report) had its price target increased by Cantor Fitzgerald from $82.00 to $90.00 in a report released on Friday, Benzinga reports. They currently have an overweight rating on the stock. Other research analysts also recently issued reports about the stock. TheStreet raised shares of Centene from a c+ rating to a […]

Centene (NYSE:CNC – Free Report) had its price target raised by Wells Fargo & Company from $74.00 to $82.00 in a report published on Wednesday morning, Benzinga reports. Wells Fargo & Company currently has an equal weight rating on the stock. Several other research firms have also weighed in on CNC. Morgan Stanley lowered shares […]

The Center on Health Equity and Access offers updates on recent news, breakthroughs in research, and ongoing initiatives aimed at tackling health care disparities and enhancing overall access to top-notch care.